Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Map3k3em1/Cya
Common Name:
Map3k3-KO
Product ID:
S-KO-08489
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Map3k3-KO
Strain ID
KOCMP-26406-Map3k3-B6J-VB
Gene Name
Map3k3
Product ID
S-KO-08489
Gene Alias
MAPKKK3; Mekk3; mKIAA4031
Background
C57BL/6JCya
NCBI ID
26406
Modification
Conventional knockout
Chromosome
11
Phenotype
MGI:1346874
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Map3k3em1/Cya mice (Catalog S-KO-08489) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000002044
NCBI RefSeq
NM_011947
Target Region
Exon 3
Size of Effective Region
~0.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Map3k3, also known as Mitogen-activated protein kinase kinase kinase 3, is ubiquitously expressed and activated by various extracellular stimuli. It belongs to the serine/threonine protein kinase family and plays a role in regulating processes like cell proliferation, differentiation, and in pathways such as NF-κB, ERK1/2, JNK, p38, and Hippo-YAP [4,5,6]. It is also involved in angiogenesis and endothelial cell function, thus having significance in vascular-related biology. Genetic models, such as mouse models, are valuable for studying its functions.

In the context of cerebral and spinal cord cavernous malformations (CCMs), somatic mutations in Map3k3, especially the c.1323C>G (p.Ile441Met) mutation, have been identified. Around 40% of patients with sporadic CCMs have this specific Map3k3 mutation [1,3]. Mouse models with Map3k3I441M uniquely expressed in CNS endothelium developed pathological phenotypes similar to human CCMs, revealing that a single genetic hit in Map3k3 can cause CCMs. The lesions initiated with endothelial expansion followed by blood-brain barrier disruption, and could be alleviated by rapamycin treatment [1]. Additionally, in vitro and in vivo experiments showed that overexpression of the Map3k3 mutation perturbed angiogenesis. Also, single-cell RNA sequencing in Map3k3I441M mice found enrichment of the apoptosis pathway in a subset of brain endothelial cells, and Map3k3I441M overexpression activated p38 signaling associated with endothelial cell apoptosis [2].

In conclusion, Map3k3 is a key regulator in multiple cellular processes and signaling pathways. Its role in CCMs, as revealed through mouse models, has provided insights into the pathogenesis of this vascular disorder. These findings suggest that targeting Map3k3 could potentially be a therapeutic strategy for CCMs, and further understanding its functions may offer more opportunities for treating related diseases.

References:

1. Ren, Jian, Huang, Yazi, Ren, Yeqing, Hong, Tao, Ge, Woo-Ping. . Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations. In Brain : a journal of neurology, 146, 3634-3647. doi:10.1093/brain/awad104. https://pubmed.ncbi.nlm.nih.gov/36995941/

2. Huo, Ran, Yang, Yingxi, Sun, Yingfan, Wang, Jiguang, Cao, Yong. 2023. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation. In Angiogenesis, 26, 295-312. doi:10.1007/s10456-023-09866-9. https://pubmed.ncbi.nlm.nih.gov/36719480/

3. Weng, Jiancong, Yang, Yingxi, Song, Dong, Wang, Jiguang, Cao, Yong. 2021. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. In American journal of human genetics, 108, 942-950. doi:10.1016/j.ajhg.2021.04.005. https://pubmed.ncbi.nlm.nih.gov/33891857/

4. Park, Sanghyun, Ryu, Won-Ji, Kim, Tae Yeong, Kim, Min Hwan, Kim, Joon. 2024. Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation. In Experimental & molecular medicine, 56, 987-1000. doi:10.1038/s12276-024-01210-5. https://pubmed.ncbi.nlm.nih.gov/38622197/

5. Jia, Wei, Dong, Yuling, Tao, Lin, Yuan, Xianglin, Li, Feng. 2015. MAP3K3 overexpression is associated with poor survival in ovarian carcinoma. In Human pathology, 50, 162-9. doi:10.1016/j.humpath.2015.12.011. https://pubmed.ncbi.nlm.nih.gov/26997451/

6. Zhang, Ying, Wang, Sha-Sha, Tao, Lin, Jia, Wei, Li, Feng. 2019. Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma. In Scientific reports, 9, 8401. doi:10.1038/s41598-019-44835-7. https://pubmed.ncbi.nlm.nih.gov/31182739/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest